Biotechnology Government Value creation 
Jake Jorgovan
NOVEMBER 29, 2023
They cater to a diverse range of companies, including startups, established biotechnology, pharmaceutical, diagnostics/device, bioinformatics, and medical/high-tech blended companies. BioPharma Excellence BioPharma Excellence specializes in biotechnology, offering strategic, insightful, and proactive support across the product journey.
BTD Consulting
DECEMBER 28, 2020
From pharmaceuticals & biotechnology to software & hardware to banking to oil & gas, alliances and JVs have reshaped competition. By turning integration from merely a project-management exercise into a value-creation one, our clients orchestrated their activities toward developing and extending critical capabilities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TIM Review
OCTOBER 30, 2020
Impactful sustainable innovation opens new global market opportunities, fosters smart specialization of regions, and spurs long-term policy actions by governments (Boons et al., 2012; Klewitz & Hansen, 2014;), sustainable value-creation strategies (Lampikoski et al., 2014), sustainable innovation (Nidumolu et al.,
TIM Review
OCTOBER 30, 2020
The “business model” concept has indeed been utilized to comprehensively understand how companies do business and perform processes of value creation, capture, and delivery (Schneider & Spieth, 2013; Foss & Saebi, 2017). Health Care : Equipment and services, pharmaceuticals, biotechnology, life science.
TIM Review
FEBRUARY 27, 2021
The term “bioeconomy” covers multiple scientific fields and interrelated perspectives highlighting biotechnology, bio-resources, and bio-ecology (Bugge et al., Social media as a new playing field for the governance of agro-food sustainability. If we don't change, we don't grow. . Gail Sheehy. Introduction . 2015; Udovita, 2020).
LaVoie Health Science Blog
JULY 16, 2021
Paul Sagan, Vice President of Investor Relations and Corporate Communications, discusses the growing investment case for ESG reporting within the biotechnology field, the unique challenges of developing an ESG approach in the life sciences, and the important considerations posed by potential new SEC recommendations and international ESG standards.
Jake Jorgovan
FEBRUARY 5, 2025
They cater to a diverse range of companies, including startups, established biotechnology, pharmaceutical, diagnostics/device, bioinformatics, and medical/high-tech blended companies. BioPharma Excellence BioPharma Excellence specializes in biotechnology, offering strategic, insightful, and proactive support across the product journey.
Expert insights. Personalized for you.
130 
Let's personalize your content